Multiple Sclerosis Resource Centre Aimspro (Goats Serum)

Saturday, 31 July 2010

The MS 24 Hour Telephone Counselling Service 0800 783 0518 (then press 1)

Search this site



Information
Home
Site Map
About MS
MSRC Services
Get Involved
MS Research News
New Discoveries
Drugs
Disease Modifying Drugs
Low Dose Naltrexone - Latest News
Sativex®
Ampyra (Fampridine-SR)
Gilenia® (FTY720)
Movectro (Cladribine)
Aimspro (Goats Serum)
Aimspro Latest News
Aimspro - Published Research Papers
Aimspro - Oxford Optic Neuritis Trial
Azathioprine
Trimesta (Oral Estriol)
Mitoxantrone and Copaxone Combination Therapy
Laquinimod
Teriflunomide
MBP8298
NeuroVax
Tovaxin
BHT-3009
HiCy
CHR-1103
BG-12
Zenapax (daclizumab)
Rituximab (Rituxan)
Cyclophosphamide
Novantrone (Mitoxantrone)
Campath
MN-166 (Ibudilast)
RPI-78M
ATX-MS-1467
RTL-1000
Further Possible MS Drugs and Treatments
Cannabis And Cannabinoid Research
Minocycline
Statins
Modafinil
Pycnogenol
Viagra (sildenafil)
Possible Drugs For The Treatment Of MS Symptoms
Genetically Modified Drugs And Components
Prokarin
Esperanza Homeopathic NeuroPeptide
PEGylated interferon beta-1a
Endo-parasites & 'Helpful' Organisms
MS Knowledge
Paediatric Multiple Sclerosis Research
Stem Cell Research & Treatment
MS and Genetics Research
Familial Risk of Multiple Sclerosis Research
Environmental Factors And MS Research
General Research News
Quality Of Life Research
Diet
Vitamin D Research
Cognition and Cognitive Issues Research
Other Conditions Research
Sex
Alternative Therapies
Exercise
General Health
Vaccinations & MS Research
Bone Marrow Transplant Research
Mercury Amalgam Fillings Research
Vitamin B12 Research
Optical Assessments and MS Diagnosis Research
Botox Research
Myelin Research
Ethnic Groups and MS Research
Neuropsychiatric and Psychological Research
Pain Research
Pregnancy And MS Research
Hyperbaric Oxygen Therapy Research
General Research Articles
MS Meeting News
MSRC Groups
Useful Resources
The Best Bet Diet Group
Advertising
Current Vacancies At MSRC
MSRC Guest Book

Interactive
Join Us
Member Log In
My MSRC
Contact MSRC
Site Map


content management system by:

You are here :

Home : MS Research News : Drugs : Aimspro (Goats Serum)

Aimspro (Goats Serum)	Print this page
	Share \|

Aimspro is available now , on the Specials Named Patient Basis , which is when a doctor writes a prescription for the UNLICENSED medication and the patient covers the cost.

Aimspro News
To keep up to date with all the latest Aimspro News please click here.

Published Scientific Papers on Aimspro
To read the published scientific papers on Aimspro please click here

The Oxford Optic Neuritis Trial
To read about the Oxford Optic Neuritis Trial please click here

Daval International
Aimspro is produced by Daval International.

© Multiple Sclerosis Resource Centre

Related Items

Aimspro - Oxford Optic Neuritis Trial

Aimspro - Published Research Papers

Aimspro Latest News

Ampyra (Fampridine-SR)

ATX-MS-1467

Azathioprine

BG-12

BHT-3009

Campath

Cannabis And Cannabinoid Research

CHR-1103

Cyclophosphamide

Disease Modifying Drugs

Esperanza Homeopathic NeuroPeptide

Further Possible MS Drugs and Treatments

Genetically Modified Drugs And Components

Gilenia® (FTY720)

HiCy

Laquinimod

Low Dose Naltrexone - Latest News

MBP8298

Minocycline

Mitoxantrone and Copaxone Combination Therapy

MN-166 (Ibudilast)

Modafinil

Movectro (Cladribine)

NeuroVax

Novantrone (Mitoxantrone)

PEGylated interferon beta-1a

Possible Drugs For The Treatment Of MS Symptoms

Prokarin

Pycnogenol

Rituximab (Rituxan)

RPI-78M

RTL-1000

Sativex®

Statins

Teriflunomide

Tovaxin

Trimesta (Oral Estriol)

Viagra (sildenafil)

Zenapax (daclizumab)

Did you find this information useful? Would you like to comment on this page? Let us know what you think! We welcome all comments and feedback on any aspect of our website - please click here to contact us.